Cardiovascular surgery devices market seen growing to $2.06B by 2030

The Business Research Company says the global cardiovascular surgery devices and equipment market will rise from $1.82 billion in 2026 to $2.06 billion by 2030, driven by less invasive procedures, AI-assisted planning and new surgical platforms. North America held the largest regional share in 2025, while an aging population is expected to keep demand growing.

Why it matters: - The cardiovascular surgery devices market sits behind procedures that repair blocked or damaged heart structures and support patient survival. - Demand is rising as cardiovascular disease, aging populations and adoption of less invasive surgery increase pressure on hospitals and device makers. - The market outlook points to a shift toward higher-precision tools, hybrid operating rooms and AI-supported planning.

What happened: - The Business Research Company released its Cardiovascular Surgery Devices And Equipment Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035 on July 30, 2026. - The report puts the market at $1.8 billion in 2025 and $1.82 billion in 2026, a 0.7% CAGR. - The report projects the market will reach $2.06 billion by 2030, with a 3.1% CAGR. - Download a free sample of the report. - View the full market report.

The details: - The report says recent growth has come from more cardiovascular disorders, more cardiac surgeries, wider access to advanced surgical tools, growth in specialized heart hospitals and greater use of bypass and ablation devices. - The report links future growth to more minimally invasive cardiac procedures, investment in advanced surgical platforms, hybrid cardiac operating rooms, AI-assisted surgical planning and ongoing product innovation. - The report expects key trends to include wider use of minimally invasive devices, improved cardiac ablation technologies, better precision in cardiopulmonary bypass systems, more beating-heart surgery and a stronger focus on surgical outcomes. - Cardiovascular surgery equipment is used to repair structural issues in the heart and blood vessels, including damaged or blocked valves and vessels. - The equipment is designed to help restore function and improve patient survival rates. - The report says the growing geriatric population is a major demand driver. - The World Health Organization said in October 2025 that the number of people age 80 and older worldwide is expected to triple to 426 million between 2020 and 2050. - North America held the largest share of the global market in 2025. - Western Europe ranked second. - The report also covers Asia-Pacific, South East Asia, Eastern Europe, South America, the Middle East and Africa. - The 2026 report adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel forecasting dashboards, market hotspot infographics, and updated graphics and tables.

Between the lines: - The forecast suggests the market is moving from slow expansion to a more durable growth phase by the end of the decade. - The strongest demand themes are less invasive procedures and automation, which can reduce surgical risk and broaden the range of patients who can be treated. - North America's lead signals that adoption of advanced cardiovascular surgery tools remains most mature in markets with stronger healthcare infrastructure.

What's next: - Device makers and investors are likely to focus on minimally invasive systems, ablation tools and bypass technologies as the market expands. - Hospitals may continue shifting toward hybrid operating rooms and AI-guided planning as cardiac surgery becomes more technology-intensive. - Regional growth patterns will likely vary with healthcare investment and access to advanced surgical systems.

The bottom line: - The cardiovascular surgery devices market is still relatively small, but the report points to steady growth through 2030 as aging populations and less invasive surgery reshape demand.